Daniel A. Vaena

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Padmanee Sharma, Margitta Retz, Arlene O. Siefker‐Radtke et al. · The Lancet Oncology · 2017 · 1.7K citations

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +6

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2008 · 906 citations · Full text

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Timothy D. Gilligan, Daniel W. Lin, Rahul Aggarwal et al. · Journal of the National Comprehensive Cancer Network · 2019 · 440 citations

Surgical Oncology, Cancer Management, Gynecology +17

Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial

Bernard Escudier, Thomas Powles, Robert J. Motzer et al. · Journal of Clinical Oncology · 2018 · 154 citations · Full text

New Standard, Cancer Management, Pharmacotherapy +16

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen

Justin P. Dassie, Luiza I. Hernandez, Gregory S. Thomas et al. · Molecular Therapy · 2014 · 103 citations · Full text